Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Doripenem in the Treatment of Complicated Intra-Abdominal Infections

This study has been completed.
Sponsor:
Collaborator:
Peninsula Pharmaceuticals, Inc.
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
ClinicalTrials.gov Identifier:
NCT00210938
First received: September 13, 2005
Last updated: June 8, 2011
Last verified: April 2010